Jose M. Cozar-Olmo
Granada, AN, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 100 publications
Recommendations for the prevention and treatment of adverse effects of intravesical BCG.
Journal: Actas urologicas espanolas
Published: March 02, 2026
Optimizing triple therapy in patients with metastatic hormone-sensitive prostate cancer.
Journal: Actas urologicas espanolas
Published: June 05, 2024
Consensus document on the implications of standardization of BCG supply in the management of patients with non-muscle-invasive bladder cancer.
Journal: Actas urologicas espanolas
Published: May 30, 2024
Why is it necessary to produce a BCG strain in Spain?
Journal: Actas urologicas espanolas
Published: January 12, 2024
Abiraterone in low-volume metastatic hormone-sensitive prostate cancer. Authors' reply.
Journal: Actas urologicas espanolas
Published: April 27, 2023
A multidisciplinary consensus statement on the optimal pharmacological treatment for metastatic hormone-sensitive prostate cancer.
Journal: Actas urologicas espanolas
Published: December 15, 2022
Hormone sensitive protocol for metastatic prostate cancer, an update.
Journal: Actas urologicas espanolas
Published: July 22, 2022
Efficacy and Tolerability of 6-Month Treatment with Tamsulosin Plus the Hexanic Extract of Serenoa repens versus Tamsulosin Plus 5-Alpha-Reductase Inhibitors for Moderate-to-Severe LUTS-BPH Patients: Results of a Paired Matched Clinical Study.
Journal: Journal of clinical medicine
Published: May 05, 2022
Type 2 Diabetes-Related Variants Influence the Risk of Developing Prostate Cancer: A Population-Based Case-Control Study and Meta-Analysis.
Journal: Cancers
Published: March 29, 2022
The impact of psychiatric pathology on the prognosis and survival of men with prostate cancer undergoing radical prostatectomy.
Journal: Actas urologicas espanolas
Published: February 22, 2022
Efficacy and Safety of the Hexanic Extract of Serenoa repens vs. Watchful Waiting in Men with Moderate to Severe LUTS-BPH: Results of a Paired Matched Clinical Study.
Journal: Journal of clinical medicine
Published: December 22, 2021
Non-metastatic castration-resistant prostate cancer: management recommendations.
Journal: Actas urologicas espanolas
Published: November 12, 2021
Last Updated: 09/26/2026